Oct 27, 5:03 PM ET
Universal Health Services reported third-quarter 2026 net income attributable to UHS of $308.7 million, or $5.22 per diluted share, down from $373.0 million, or $5.86 per diluted share, a year earlier. Net revenues rose 5.3% to $4.733 billion, and the company said a tentative settlement of the Cumberland Litigation drove a $26 million reserve increase, which shareholders should weigh against the higher revenue.
- Q3 2026 net income attributable to UHS was $308.7 million, or $5.22 per diluted share, versus $373.0 million, or $5.86, in Q3 2025
- Net revenues rose 5.3% to $4.733 billion from $4.495 billion
- A $26 million pre-tax reserve increase tied to the tentative Cumberland settlement was partly offset by $47 million in favorable Medicaid supplemental payments
- Repurchased 1.35 million shares for about $242.1 million in Q3; about $735.4 million remained under the authorization as of September 30, 2026
Read the filing on SEC.gov ↗
Aug 21, 7:58 AM ET
On August 20, 2026, Universal Health Services completed a public offering of $600 million of 5.500% senior secured notes due 2031 and $500 million of 6.000% senior secured notes due 2036. The notes are guaranteed by subsidiaries and secured by first-priority liens on certain assets, ranking equally with the company's senior secured credit facility and five series of existing secured notes. The filing adds $1.1 billion of secured debt, and notes that some underwriter affiliates will receive proceeds as repayment of revolving credit facility borrowings.
- $600 million 5.500% senior secured notes mature September 1, 2031; callable before August 1, 2031 at par plus accrued interest and a make-whole premium.
- $500 million 6.000% senior secured notes mature September 1, 2036; callable before June 1, 2036 at par plus accrued interest and a make-whole premium.
- Interest is payable semi-annually on March 1 and September 1, starting March 1, 2027.
- Moody's and S&P rated the notes investment grade at issuance, but the filing says collateral release conditions were not met as of that date.
Read the filing on SEC.gov ↗
Aug 13, 9:23 AM ET
Universal Health Services agreed on August 11, 2026 to sell $1.1 billion of senior secured notes through underwriters led by J.P. Morgan, BofA Securities, Truist, U.S. Bancorp and Wells Fargo. The filing says the company's revolving credit facility borrowings will be repaid from the proceeds, and it notes J.P. Morgan is also the company's financial advisor on its proposed acquisition of Talkspace, Inc.
- Two tranches: $600 million of 5.500% notes due 2031 and $500 million of 6.000% notes due 2036
- Notes are guaranteed on a senior secured basis by the company's subsidiary guarantors and sold under an S-3 shelf registration
- Proceeds will be used in part to repay outstanding borrowings under the revolving credit facility
- Underwriting agreement dated August 11, 2026; prospectus supplement filed with the SEC on August 13, 2026
Read the filing on SEC.gov ↗
Jul 28, 8:19 AM ET
Universal Health Services reported second-quarter 2026 net income attributable to UHS of $358.4 million, or $5.98 per diluted share, up from $353.2 million, or $5.43, a year earlier, on net revenues up 8.3% to $4.638 billion. The company also lowered the midpoint of its 2026 adjusted EPS forecast by 2.6% to a range of $22.28 to $23.65, which means shareholders face a lower earnings outlook than the company gave in February.
- Q2 2026 net income attributable to UHS was $358.4 million, or $5.98 per diluted share, versus $5.43 a year earlier; the company reported no adjustments for the quarter.
- Q2 results included a net pre-tax benefit of about $72 million: $100 million from the Florida Medicaid managed care directed payment program, less a $28 million increase to professional and general liability reserves.
- Revised 2026 adjusted EPS-diluted forecast is $22.28 to $23.65 per share, down from $22.64 to $24.52 in the original forecast; the midpoint of adjusted EBITDA net of NCI fell 1.9%.
- The company repurchased 1.890 million shares in Q2 2026 for about $320.3 million, with about $977.6 million of authorization remaining as of June 30, 2026.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.